17Dec/20
New PROTAC Interim Data Released—Potential ARV-471 Won Arvinas Doubled Shares
On December 14, 2020, Arvinas released the latest clinical data of ARV-471 and ARV-110, which showed strong therapeutic potential. As soon as the news was released, Arvinas’s share price doubled, with aRead More…